Myomo, Cambridge, Massachusetts, announced the expansion of its management team with three new positions in medical affairs, sales, and marketing. The expansion marks the company’s accelerated commercialization of its MyoPro line of powered orthoses after raising growth capital through its initial public offering in June.
Brandon Green, DO, BOCP, has assumed the role of chief medical officer. Green will conduct clinical presentations and training for physicians and other clinicians. Additionally, he will engage with private and government payers on reimbursement policies for the MyoPro product line and participate in the design and review of clinical studies in conjunction with the company’s scientific advisory board. Green is trained in general surgery and rehabilitation medicine, and specializes in upper-limb prosthetics.
Lorraine Hale has been named as the national business development manager. Hale will oversee the company’s business and enterprise development with medical clinicians, the Veterans Health Administration, and O&P practitioners. She will support the sales team in their efforts to increase the clinical adoption of MyoPro. Hale has sales and management experience in the medical device industry and previously worked at Touch Bionics, Livingston, Scotland.
Cliff Conneighton is the new chief marketing officer. He is responsible for the company’s marketing strategy and programs in support of the MyoPro line and the company’s Centers of Excellence, Conneighton will oversee the company’s advertising, public relations, and social media activity, in addition to MyoPro product management. He has experience in scaling businesses for growth, having served as chief marketing officer for four technology companies.
Myomo plans to add field sales and clinical staff in regional locations across the United States as the company seeks to establish additional Centers of Excellence. Myomo is also preparing to launch MyoPro in Germany in partnership with Ottobock, Duderstadt, Germany.
